| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/14/2006 | EP1667973A2 Quinoline potassium channel inhibitors |
| 06/14/2006 | EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 06/14/2006 | EP1667682A2 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 06/14/2006 | EP1667679A1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 06/14/2006 | EP1667647A2 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1587877B1 Beta-isoindigo coloring agent |
| 06/14/2006 | EP1567507B1 1,2,3- triazole amide derivatives as cytokine inhibitors |
| 06/14/2006 | EP1437385B1 Novel anthrapyridone compounds,water-base magenta ink compositions,and ink-jet recording process |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1341759B1 3-substituted oxindole beta 3 agonists |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | DE4410606B4 Cyanopyrimidin-Derivate und flüssigkristallines Medium Cyanopyrimidine derivatives and liquid crystalline medium |
| 06/14/2006 | CN1788006A Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 06/14/2006 | CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor |
| 06/14/2006 | CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers |
| 06/14/2006 | CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/14/2006 | CN1259318C Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient |
| 06/14/2006 | CN1259317C Derivant of electrophosphorescence 1,8-naphthimide and luminous ligand thereof |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | USRE39131 Heterocyclic compounds |
| 06/13/2006 | USRE39130 iNSECTICIDES; CONTAINING A 2-CYANOIMINO GROUP ON HETEROCYCLIC RING |
| 06/13/2006 | USRE39129 Insecticides; containing a 2-cyanoimino group attached to heterocyclic ring |
| 06/13/2006 | USRE39127 Heterocyclic compounds |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/13/2006 | US7060839 Process for the preparation of pantoprazole and intermediates therefor |
| 06/13/2006 | US7060837 Method for the purification of lansoprazole |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060833 Reacting 6-hydroxy-3,4-dihydroquinoline with 1-cyclohexyl-5-(halbutyl)tetrazole in presence of a base |
| 06/13/2006 | US7060829 Colorant compounds containing copolymerizable vinyl groups |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060822 2-pyrazolin-5-ones |
| 06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
| 06/13/2006 | US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents |
| 06/13/2006 | US7060717 Phosphodiesterase inhibitor; antiinflammatory agents; antiallergens; respiratory system disorders; wound healing agents |
| 06/13/2006 | US7060711 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060704 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders |
| 06/13/2006 | US7060703 Indolinone derivatives |
| 06/13/2006 | US7060702 Chemical compounds |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060110 Chromatic direct dyes |
| 06/13/2006 | CA2249562C Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
| 06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
| 06/13/2006 | CA2158981C Herbicidal heterocyclic-substituted pyridines |
| 06/13/2006 | CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006060762A2 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/08/2006 | WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors |
| 06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | WO2006060318A2 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 06/08/2006 | WO2006060198A1 Translation lookaside buffer (tlb) access supression for intra-page program counter relative or absolute address branch instructions |
| 06/08/2006 | WO2006060127A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/08/2006 | WO2006060122A2 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 06/08/2006 | WO2006059945A1 Novel compounds |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | WO2006058700A1 Acetamide compounds as fungicides |
| 06/08/2006 | WO2006044602A9 Diphenyl substituted alkanes as flap inhiibitors |
| 06/08/2006 | WO2006035280A8 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2006011024A9 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/08/2006 | WO2005120584A3 Radiolabeled arylsulfonyl compounds and uses thereof |
| 06/08/2006 | WO2005105787A8 Rapid and robust 3d/3d registration technique |
| 06/08/2006 | US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems |
| 06/08/2006 | US20060122396 Into a difluorobenzoic acid, for producting quinolonecarboxylic acid serving as synthetic antibacterial agent, medicament, agricultural chemical, or veterinary drug; ionic liquid solvents |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122235 Amine oxidase inhibitor; use in treating Alzheimer's disease; for example, (RS)-1-[6-(4-fluoro-benzyloxy)-pyridin-3-yl]-5-oxo-pyrrolidine-3-carboxylic acid methylamide |
| 06/08/2006 | US20060122233 Rabeprazole calcium |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122230 1,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
| 06/08/2006 | US20060122222 Heterocycle substituted carboxylic acids |
| 06/08/2006 | US20060122207 Imidazol derivatives as Raf kinase inhibitors |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122197 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122192 Chemical compounds |
| 06/08/2006 | US20060122171 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
| 06/08/2006 | US20060122169 Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
| 06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 06/08/2006 | US20060122063 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 06/08/2006 | US20060122062 2,2,2-trifluoro-N-[5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridinylidene]-acetamide; herbicides; 1-phenylazinethione and 1-phenylchloroazinium intermediates; 1-phenylpyridones: 5-methyl-1-(3-trifluoromethyl-phenyl)-2(1H)-pyridinone |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | US20060119254 Neutral metallic dendrimer complexes |
| 06/08/2006 | US20060117991 Phase change inks; piezoelectric printing |
| 06/08/2006 | CA2738383A1 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |